ALLC
geneOn this page
Also known as ALC
Summary
ALLC (allantoicase, HGNC:17377) is a protein-coding gene on chromosome 2p25.3, encoding Probable inactive allantoicase (Q8N6M5). The function of this enzyme is unclear as allantoicase activity is not known to exist in mammals.
Allantoicase (EC 3.5.3.4) participates in the uric acid degradation pathway. Its enzymatic activity, like that of urate oxidase (MIM 191540), was lost during vertebrate evolution.
Source: NCBI Gene 55821 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 68 total
- MANE Select transcript:
NM_018436
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17377 |
| Approved symbol | ALLC |
| Name | allantoicase |
| Location | 2p25.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ALC |
| Ensembl gene | ENSG00000151360 |
| Ensembl biotype | protein_coding |
| OMIM | 612396 |
| Entrez | 55821 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 1 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000252505, ENST00000471711, ENST00000476389
RefSeq mRNA: 1 — MANE Select: NM_018436
NM_018436
CCDS: CCDS46223
Canonical transcript exons
ENST00000252505 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000893309 | 3682942 | 3683074 |
| ENSE00000893310 | 3681634 | 3681713 |
| ENSE00000893311 | 3679869 | 3679994 |
| ENSE00000893312 | 3678468 | 3678555 |
| ENSE00001146000 | 3674075 | 3674125 |
| ENSE00001189790 | 3671096 | 3671190 |
| ENSE00001830659 | 3658200 | 3658294 |
| ENSE00003521267 | 3701512 | 3701636 |
| ENSE00003606448 | 3696275 | 3696348 |
| ENSE00003627263 | 3697348 | 3697456 |
| ENSE00003645787 | 3695717 | 3695872 |
| ENSE00003666875 | 3702363 | 3702671 |
Expression profiles
Bgee: expression breadth ubiquitous, 139 present calls, max score 96.12.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0468 / max 47.8150, expressed in 6 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 18644 | 0.0401 | 6 |
| 202064 | 0.0067 | 3 |
Top tissues by expression
268 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 96.12 | gold quality |
| male germ cell | CL:0000015 | 92.94 | gold quality |
| right testis | UBERON:0004534 | 87.36 | gold quality |
| left testis | UBERON:0004533 | 87.14 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.41 | gold quality |
| testis | UBERON:0000473 | 84.15 | gold quality |
| tibial nerve | UBERON:0001323 | 80.59 | gold quality |
| right lobe of liver | UBERON:0001114 | 71.25 | gold quality |
| adult organism | UBERON:0007023 | 68.72 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 65.59 | gold quality |
| gall bladder | UBERON:0002110 | 64.80 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 63.61 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 63.05 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 62.15 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 61.79 | gold quality |
| liver | UBERON:0002107 | 61.67 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 61.56 | gold quality |
| diaphragm | UBERON:0001103 | 61.27 | gold quality |
| right adrenal gland | UBERON:0001233 | 60.54 | gold quality |
| left adrenal gland | UBERON:0001234 | 60.43 | gold quality |
| sural nerve | UBERON:0015488 | 60.36 | gold quality |
| adrenal cortex | UBERON:0001235 | 60.19 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 58.81 | gold quality |
| gluteal muscle | UBERON:0002000 | 58.41 | gold quality |
| superficial temporal artery | UBERON:0001614 | 58.27 | gold quality |
| triceps brachii | UBERON:0001509 | 58.23 | gold quality |
| adrenal gland | UBERON:0002369 | 57.50 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 57.13 | gold quality |
| quadriceps femoris | UBERON:0001377 | 56.50 | gold quality |
| parotid gland | UBERON:0001831 | 56.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.77 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
8 targeting ALLC, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3934-5P | 99.67 | 64.04 | 846 |
| HSA-MIR-12132 | 99.47 | 68.90 | 1341 |
| HSA-MIR-4733-3P | 98.35 | 65.20 | 994 |
| HSA-MIR-4669 | 97.94 | 62.71 | 224 |
| HSA-MIR-204-3P | 97.80 | 66.84 | 1656 |
| HSA-MIR-4646-5P | 97.70 | 66.84 | 1692 |
| HSA-MIR-10525-3P | 96.32 | 68.04 | 699 |
| HSA-MIR-6784-5P | 84.56 | 60.91 | 126 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | allc | ENSDARG00000042562 |
| mus_musculus | Allc | ENSMUSG00000020636 |
| rattus_norvegicus | Dcdc2c | ENSRNOG00000008299 |
Protein
Protein identifiers
Probable inactive allantoicase — Q8N6M5 (reviewed: Q8N6M5)
Alternative names: Allantoate amidinohydrolase
All UniProt accessions (1): Q8N6M5
UniProt curated annotations — full annotation on UniProt →
Function. The function of this enzyme is unclear as allantoicase activity is not known to exist in mammals.
Polymorphism. Product of a polymorphic gene which also produces a longer 410-residue protein due to a polymorphism which affects Met-1, resulting in a longer protein starting at an upstream Met.
Similarity. Belongs to the allantoicase family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N6M5-1 | 1 | yes |
| Q8N6M5-2 | 2 |
RefSeq proteins (1): NP_060906* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005164 | Allantoicase | Family |
| IPR008979 | Galactose-bd-like_sf | Homologous_superfamily |
| IPR015908 | Allantoicase_dom | Domain |
Pfam: PF03561
UniProt features (6 total): sequence conflict 3, chain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N6M5-F1 | 91.83 | 0.85 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 62 (showing top):
chr2p25, GOBP_RESPONSE_TO_METAL_ION, GOBP_RESPONSE_TO_MAGNESIUM_ION, GOBP_AMIDE_METABOLIC_PROCESS, TGACATY_UNKNOWN, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, GOBP_RESPONSE_TO_PH, KEGG_PURINE_METABOLISM, SHEN_SMARCA2_TARGETS_DN, GOBP_RESPONSE_TO_CALCIUM_ION, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, ATF2_UP.V1_UP, NOTCH_DN.V1_DN
GO Biological Process (1): allantoin catabolic process (GO:0000256)
GO Molecular Function (1): allantoicase activity (GO:0004037)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| allantoin metabolic process | 1 |
| catabolic process | 1 |
| hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines | 1 |
Protein interactions and networks
STRING
901 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ALLC | MYC | P01106 | 742 |
| ALLC | FOS | P01100 | 569 |
| ALLC | EGFR | P00533 | 500 |
| ALLC | DENND11 | A4D1U4 | 454 |
| ALLC | MPL | P40238 | 440 |
| ALLC | AP1M1 | Q9BXS5 | 430 |
| ALLC | SRC | P12931 | 429 |
| ALLC | SEC61A2 | Q9H9S3 | 425 |
| ALLC | PMFBP1 | Q8TBY8 | 420 |
| ALLC | KIT | P10721 | 419 |
| ALLC | PCNX1 | Q96RV3 | 418 |
| ALLC | GTF3C5 | Q9Y5Q8 | 416 |
| ALLC | PREB | Q9HCU5 | 410 |
| ALLC | COL9A1 | P20849 | 401 |
| ALLC | CLEC14A | Q86T13 | 393 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GLI1 | TP53 | psi-mi:“MI:0914”(association) | 0.350 |
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): ALLC (Affinity Capture-MS), ALLC (Affinity Capture-MS)
ESM2 similar proteins: A1L1F0, A4IFG2, A5A6P1, A5GFY8, C3K0A7, D9IVE5, O43175, P10688, P10895, P18407, P25335, Q01415, Q02JZ8, Q09913, Q0V9A9, Q1ED21, Q2KIG4, Q32NH8, Q3B8C3, Q3KFK9, Q3TV70, Q48KS4, Q4K8H3, Q4R964, Q4ZVG8, Q58DU8, Q5EAD2, Q5PQR3, Q5R6J8, Q5R7M2, Q61753, Q640T1, Q68FH4, Q6AYP0, Q6DGA6, Q6LPX9, Q86WQ0, Q87YX4, Q8BIP0, Q8C726
Diamond homologs: A3MA02, A4VP32, A6V7Y9, B0V9T8, B0VP26, B2I1L5, B2UG65, B7GV54, B7ICG5, B7UW33, C3K0A7, P18407, P25335, Q02JZ8, Q09913, Q2KIG4, Q3KFK9, Q48KS4, Q4K8H3, Q4R964, Q4ZVG8, Q54VL5, Q5YP02, Q62H14, Q62JH0, Q63QS9, Q63T53, Q640T1, Q6AYP0, Q6DGA6, Q6F6Y1, Q6LPX9, Q82LL5, Q87YX4, Q8N6M5, Q8XUB7, Q92VC1, Q9I3J8, Q9JHX6, Q9RKU4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
68 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 55 |
| Likely benign | 5 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2211 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:3671093:CA:C | acceptor_loss | 1.0000 |
| 2:3671094:A:AG | acceptor_gain | 1.0000 |
| 2:3671095:G:GG | acceptor_gain | 1.0000 |
| 2:3671095:GGAA:G | acceptor_gain | 1.0000 |
| 2:3671187:AAAAG:A | donor_loss | 1.0000 |
| 2:3671188:AAAG:A | donor_loss | 1.0000 |
| 2:3671190:AG:A | donor_loss | 1.0000 |
| 2:3671191:G:GG | donor_gain | 1.0000 |
| 2:3671191:GTA:G | donor_loss | 1.0000 |
| 2:3671192:T:A | donor_loss | 1.0000 |
| 2:3679864:C:CA | acceptor_gain | 1.0000 |
| 2:3679864:CGCA:C | acceptor_loss | 1.0000 |
| 2:3679865:GCAG:G | acceptor_loss | 1.0000 |
| 2:3679866:CAG:C | acceptor_loss | 1.0000 |
| 2:3679867:A:AG | acceptor_gain | 1.0000 |
| 2:3679867:A:AT | acceptor_loss | 1.0000 |
| 2:3679868:G:GT | acceptor_gain | 1.0000 |
| 2:3679868:GGT:G | acceptor_gain | 1.0000 |
| 2:3679868:GGTC:G | acceptor_gain | 1.0000 |
| 2:3679988:G:GT | donor_gain | 1.0000 |
| 2:3679991:GAAG:G | donor_gain | 1.0000 |
| 2:3679992:AAGGT:A | donor_loss | 1.0000 |
| 2:3679993:AGGT:A | donor_loss | 1.0000 |
| 2:3679994:GGT:G | donor_loss | 1.0000 |
| 2:3679995:G:GA | donor_loss | 1.0000 |
| 2:3679996:T:G | donor_loss | 1.0000 |
| 2:3695843:C:G | donor_gain | 1.0000 |
| 2:3696346:G:GT | donor_gain | 1.0000 |
| 2:3696346:GAA:G | donor_gain | 1.0000 |
| 2:3696349:G:GG | donor_gain | 1.0000 |
AlphaMissense
2579 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:3678528:T:A | W49R | 0.983 |
| 2:3678528:T:C | W49R | 0.983 |
| 2:3696307:T:A | W234R | 0.980 |
| 2:3696307:T:C | W234R | 0.980 |
| 2:3678530:G:C | W49C | 0.972 |
| 2:3678530:G:T | W49C | 0.972 |
| 2:3682957:T:A | W132R | 0.971 |
| 2:3682957:T:C | W132R | 0.971 |
| 2:3701610:T:A | W317R | 0.966 |
| 2:3701610:T:C | W317R | 0.966 |
| 2:3696309:G:C | W234C | 0.965 |
| 2:3696309:G:T | W234C | 0.965 |
| 2:3683058:A:C | R165S | 0.957 |
| 2:3683058:A:T | R165S | 0.957 |
| 2:3679967:T:C | S91P | 0.954 |
| 2:3679971:T:A | I92N | 0.954 |
| 2:3679880:T:C | C62R | 0.953 |
| 2:3695741:T:A | V179E | 0.950 |
| 2:3702480:G:C | G365R | 0.948 |
| 2:3674081:T:C | F14L | 0.947 |
| 2:3674083:T:A | F14L | 0.947 |
| 2:3674083:T:G | F14L | 0.947 |
| 2:3678529:G:C | W49S | 0.945 |
| 2:3697390:G:C | A262P | 0.945 |
| 2:3683057:G:C | R165T | 0.943 |
| 2:3695833:T:C | F210L | 0.942 |
| 2:3695835:T:A | F210L | 0.942 |
| 2:3695835:T:G | F210L | 0.942 |
| 2:3695836:A:C | S211R | 0.942 |
| 2:3695838:T:A | S211R | 0.942 |
dbSNP variants (sampled 300 via entrez): RS1000152971 (2:3686248 G>A), RS1000173483 (2:3674291 C>T), RS1000206276 (2:3674039 G>A), RS1000268034 (2:3649584 C>A), RS1000321712 (2:3679416 T>C), RS1000328552 (2:3692767 A>C), RS1000341228 (2:3668817 C>G,T), RS1000343297 (2:3674628 T>A,C), RS1000407967 (2:3659405 G>C), RS1000426667 (2:3679201 A>G), RS1000511255 (2:3663815 C>T), RS1000519692 (2:3669783 G>C), RS1000586849 (2:3654292 G>A), RS1000680951 (2:3652964 T>C), RS1000718792 (2:3669484 C>T)
Disease associations
OMIM: gene MIM:612396 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_148 | Obesity-related traits | 2.000000e-06 |
| GCST002432_1 | Response to inhaled corticosteroid treatment in asthma (change in FEV1) | 4.000000e-07 |
| GCST002432_10 | Response to inhaled corticosteroid treatment in asthma (change in FEV1) | 4.000000e-06 |
| GCST006312_1 | Childhood dental caries in primary teeth | 4.000000e-08 |
| GCST006312_2 | Childhood dental caries in primary teeth | 4.000000e-07 |
| GCST007565_23 | Morning person | 1.000000e-13 |
| GCST007576_70 | Chronotype | 1.000000e-13 |
| GCST008503_1 | Fasting glucose change | 1.000000e-06 |
| GCST009286_1 | Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes | 9.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005921 | FEV change measurement |
| EFO:0008328 | chronotype measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| sodium arsenite | affects methylation | 1 |
| butyraldehyde | increases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | decreases methylation, affects methylation | 1 |
| Pesticides | affects methylation | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): dental caries, diabetic kidney disease